Life-threatening effects of discontinuing inhaled nitric oxide in children

Acta Paediatrica, International Journal of Paediatrics

Volumn 86, Issue 12, 1997, Pages 1337-1339

  Cueto, E ^a   Lopez Herce J ^a,b   Sanchez A ^a   Carrillo, A ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b Puentecesures   (Spain)

Author keywords

Acute respiratory distress syndrome; Children; Nitric oxide; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE;

ADOLESCENT; ARTICLE; BRONCHOPNEUMONIA; CHILD; CLINICAL ARTICLE; CRITICAL ILLNESS; HUMAN; NEWBORN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; RESPIRATORY DISTRESS SYNDROME;

EID: 0031460678     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1997.tb14909.x     Document Type: Article

References (12)

1. Rossaint R, Falke KJ, López F, Slama R, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399-405
2. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr 1994; 124: 302-8
3. Müller W, Kachel W, Lasch P, Varnholt V, König SA. Inhaled nitric oxide for avoidance of extracorporeal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn. Intensive Care Med 1996; 22: 71-6
4. Roberts JD, Polander DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818-9
5. Gerlach H, Rossaint R, Pappert D, Falke KJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23: 499-502
6. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of nitric oxide. J Pediatr 1993; 123: 103-8
7. Young JD, Dyar OJ. Delivery and monitoring of inhaled nitric oxide. Intensive Care Med 1996; 22: 77-86
8. Lavoie A, Hall JB, Olson DM, Wylan ME. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am J Respir Crit Care Med 1996; 153: 1985-7
9. Moncada S, Plamer RM, Higgs EA. Nitric oxide: physiology, physiopathology and pharmacology. Pharmacol Rev 1991; 43: 109-42
10. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12
11. Shaul PW, Wells LB, Horning KM. Acute and prolonged hypoxia attenuate endothelial nitric oxide production in rat pulmonary arteries by different mechanisms. J Cardiovasc Pharmacol 1993; 22: 819-27
12. Griscavage JM, Rogers NE, Sherman MP, Ignarro LJ. Negative feedback modulation of constitutive (c) and inducible (i) nitric oxide (NO) synthase (NOS) by NO. FASEB J 1993; 7: A243